Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
105 Cards in this Set
- Front
- Back
What metabolic effect does estrogen have?
|
Increases HDL
Increases TGs Increases clotting factors Decreases LDL, total cholesterol might increase galstone formation from incresaed cholesterol in bile and decreasd bile acid secretion |
|
When not bound to estrogens what are estrogen receptors bound to?
|
HSPs
|
|
What are the 2 different estrogen receptor genes
|
ER-alpha and ER-beta
|
|
How is ethanyl estradiol bound?
|
serum albumin
|
|
should women take estrogens if they are pregnant?
|
NO: can cause reproductive tract toxicities
|
|
What is the relationship between migraines and hormones?
|
HRT can cause severe migraines (especially estrogens)?
|
|
What are the different types of synthetic estrogens?
|
ethinyl estradiol (OC, HRT)
Mestranol (OC) DES - can cause clear cell carcinoma of the vagina |
|
What effect does tamoxifen have on bone? What is it used for?
|
Anti-resorptive effects on bone
inhibits proilf of breast ca |
|
tamoxifen effects on cholesterol??
|
decreases total cholesterol
decreases LDL decreases lipoproteins doesn't increase HDL |
|
What effects are seen with raloxifene?
|
anti-resorptive effects on bone
anti-prolif effects on some breast CAs |
|
what are the agonist/antagonist effects caused by raloxifene?
|
antoagonist effects on endometrium, ER + breast Ca
|
|
what effects does roloxifine have on cholesterol?
|
Decreases total cholesterol and LDL
no increase in HDL |
|
MOA of clomiphene
|
blocks E2 mediated negative feedback on pit, increasing LDH and FSH secretion --> enlarged ovaries and stim of ovaries
increases amp of LH and FSH w/o changing pulse frequency |
|
Use of fulvestrant
|
can treat tamoxifen resistant breast ca
|
|
What are ethe different types of aromatase inhibitors?
|
Type I (steroidal)
Type II (non-steroidal) |
|
How do nonsteroidal aromatase inhibitors work?
|
they interact reversibly with the heme group of aromatase
steroidals irreversibly inactivate aromatase |
|
What are the aromatase inhibitors?
What are they used for? |
exemastane
letrozole anastrozole treat breast Ca |
|
Benefit of aromatase inhibitors?
|
don't increase risk of uterine cancer or venous thromboembolism
lipid profile alterations unknown |
|
What effect do progestins have on neuroendocrine system?
|
Decresae frequency of GnRH pulse from hpothalamus
Increase amplitude of LH from pit |
|
What effects does progestin hvae on reproductive tract?
|
promotes secretory endometrium
decreases secretion by endocervical glands, afecting penetration of cervix by sperm suppresses menstruation and uterine contractility decresaes rate of premature labor in high risk moms |
|
What effects does progeestin have on CNS?
|
incresaes basal body temp at ovulation
increases ventilatory response of resp centers to CO2 Has depressant and ypnotic actions in CNS (give at bedtime) |
|
What effect does progestin have on cholesterol?
|
increases LDL
no effeect, r modest reduction in HDL |
|
Which hormone affects aldosterone
|
progestin
|
|
What are the different progesterone receptors and how do they differ?
|
PR-A and PR-B
They are regulated by estrogen PR-A inhibits PR-B, causes ovulation and implantation PR-B has stimulatory actions, responsible for mammary gland development |
|
what does mifepristone do?
|
antagonises PR, GC receptor and androgen receptor
(also has some progesterone agonist ability) Blocks PRs in uterus --> decidual breakdown --> detachment of blastocyst --> decreases hCG production --> decreased progesterone secretion from corpus luteum --> further accentates decidual breakdown --> increases uterine PG levels --> expulsion of blastocyst |
|
Uses of mifepristone
|
induction of labor after fetal death
tx of endometriosis, leiomyomas, br CA, and meningiomas luteal phase contraceptive |
|
What does progestin do during HRT?
|
reduces uterine cancer risk
|
|
What effect does progestin have on GnRH?
|
Diminishes frequency of GnRH pulse (impt for ovluation)
|
|
what does estrogen do to FSH?
|
suppresses FSH release from pit during follicular phase
|
|
How do progestin only pills work?
|
block ovulation in 60-80% of cycles
They diminish GnRH frequency and LH surge Also thicken cervical mucus,which decreases sprem penetration alters endometrium so implantation is impaired |
|
What does testosterone do to LH?
How much testsosterone is required for sprematoenesis? |
inhibits LH secretion
100x greater concentration required in testes testosterone cna therefore be used formale contraception |
|
What hormonens can be used to treat hives?
|
stanozolol
danazol (stimulate hepatic synthesis of antihistamines) |
|
What can be used to treat hereditary angioedema?
|
stanozolol
danazol |
|
What is the difference between abarelix and leuprolide?
|
abarelix is a GnRH antagonist (treats prostate CA, breast CA, and endometriosis)
leuprolide is a GnRH analog Both are anti-androgens |
|
What do androgen receptor antagonists do to LH and GnRH?
|
increase LH secretion which increases testosterone
used primarily wiht GnRH to treat metastatic prostate Ca |
|
Which androgen receptor antagonist has the best safety proflie?
|
bicalutamide
(flutamide = hepatotoxicity, nilutamide = bad side effects) |
|
What can flutamide treat in women?
|
hirsutism
|
|
Where are the different 5-alpha reductase receptors found?
|
I: non genital skin, liver, bone
II: urogenital tissue in men (prostate) and genital skin in men and women |
|
MOA of finasteride
|
antagonist of type II 5-alpha reductase
treats BPH (decreases prostate volume and promotes urine flow) |
|
MOA of duasteride?
|
antagonist of I and II 5-alpha reductase
treats BPH (decreases prostate volume and promotes urine flow) |
|
hydroxycholoroquine
|
treats RA
decreases RF, but doesn't slow dz requires 3-6 mo to treat |
|
leflunomide
|
inhibits pyrimadine synth by inhibiting DHODH which is needed for rUMP production
|
|
etanercept MOA
|
TNF inhibition through competitive binding of TNF-alpha
|
|
infliximab MOA
|
TNF inhibition by binding to TNF-alpha
|
|
adalimumab MOA
|
TNF inhibition
|
|
anakinra MOA
|
IL-1 antagonist
|
|
MOA piroxicam
|
COX inhibition
|
|
MOA meloxicam
|
COX 2 inhibition
|
|
MOA diclofenac
|
COX inhibitor more potent than indomethacin
|
|
MOA nabumetone
|
COX 2 inhibition
|
|
When should estrogens be given to treat osteoporosis?
|
within the first 5 yrs of menopause
|
|
MOA of estrogen on bones?
|
reduces PTH effects
|
|
MOA of calcitonin
|
decreases osteoclast fxn to slow bone demineralization
|
|
what is teriparatide?
|
fragment of PTH
|
|
MOA of teriparatide?
|
it is different than endogenous PTH... it stimulates new bone formation
(increases number and activity of osteoblasts) |
|
adverse effects of teriparatide
|
can cause incresaed incidence of osteosarcoma
|
|
MOA of bisphosphonates
|
Inhibits osteoclast fxn
stimulates osteoblasts to inhibit osteoclast fxn |
|
which bisphosphonate can lead to osteomalacia?
|
etidronate
|
|
MOA of fluordie
|
stabilizes hydroxyapatite crystals
acts as a mitogen for osteoblasts |
|
MOA plicamycin
|
cytotoxic AB to treat PAget's dz
MOA unclear |
|
adverse effects of plicamycin
|
sudden thrombocytopenia --> hemorrhage
alters liver and kidney fxn |
|
MOA azathioprine
|
purine anti-metabolite
forms thio-GTP that gets incorporated into DNA |
|
MOA mycophenolate mofetil
|
it is a form of mycophenolic acid, which inhibits monophosphate dehydrogenase (needed for do novo synthesis of purines)
B and T cells need this pathway to proliferate process is inhibited |
|
MOA of mTOR inhibitors
|
inhibits B and T cell proliferation stimulated by IL-2
Forms complex with FKBP12 that inhibits mTOR activity (mTOR = protein kinase that causes growht and expansion of T and B cells in response to IL-2) |
|
MOA tacrolimus
|
associaes with FKBP12 adn gindsd to calcinuerin to inhibit its activity in T cells
|
|
What is calcineurin
|
Substrate = NF-AT which translocates from cyotplasm to nucleus when stim by calcineurin and increases transcription of IL2 and other lymphokines
|
|
MOA daclizumab
|
mAB against activated T cells (not resting T cells)
Competitive antagonism of IL-2 induced cell prolif |
|
class of daclizumab
|
anti-cd25 mAB
|
|
MOA muromonab
|
mAB against CD3 on T cell surfaace
--> T cell depletion from blood and peripheral lymphoid organs Also reduces fxn of remaining T cells |
|
class of muromonab
|
anti CD3 mAB
|
|
Adverse effects of metformin
|
decreases B12 absorption
severe lactic acidosis |
|
contraindications of metformin
|
in states predisposing to tissue anoxia
renal insuff (cleared by kidney) |
|
How long does it take for thiozolidinediones to work?
|
weeks-months
|
|
adverse effects of thiazoladinediones
|
modest weight gain
fluid retention changes in LDL, HDL, and TGs anemia fatal liver damage, check LFTs |
|
interactions with thiazoladinediones
|
indeuce enzymes that degrade oral contraceptives (interacts with p450)
|
|
indications for alpha-glucosidase inhibitors
|
decrease postprandial plasma glucose in type 2 DM
insulin sparing!!! |
|
adverse effecdts of alpha-glucosidase inhibitors
|
gas from CHO fermentation in coln
diarrhea abdominal pain |
|
MOA exenatide
|
incretin mimetic (incretins stimulate insulin)
AA sequence similar to human glucagon like peptide !, stimulates insulin secretion, lowers serum glucagon slows gastric emptying increases satiety |
|
adverse effects of exenatide
|
N/V/D
|
|
MOA pramlintide
|
slows gastric emptying
increases satiety suppresses postprandial plasma glucoagon and hepatic glucose output |
|
Drawback of glitazone therapy
|
expensive
long-term data lacking |
|
which are the most cost effective anti-diabetic agents available?
|
sulfonylureas
|
|
MOA of sulfonylureas
|
stimulates insulin secretion from beta cells
requires working beta cells (not for DM I) |
|
MOA of glitazones
|
reduces insulin resistance by binding to nuclear receptor PPAR-gamma and increases the transcription of genes encoding proteins that mediate insulin action
|
|
structure of insulin receptor
|
2 alpha subnits that are extracellular and bind insulin
2 beta subunits that are transmembrane and posess tyrosine kinase activity |
|
what does insulin binding to receptor lead to
|
glucose transporter translocation to membrane
glycogen synthases activity incresaes increased lipogenesis enhanced DNA synthesis and cell growth/division |
|
structure of NPH
|
combo of insulin and protamine
nether is present in uncomplexed form |
|
structure of lente
|
combo of semilente and ultralente
|
|
which insulin formulation mimcs basal insulin release from pancreas of non diabetic
|
ultralente
|
|
what is exubera indicated for
|
DM I and II `
|
|
what do sulfonylureas do to K channel
|
inhibit efflux of K
|
|
what is the insulin source (human or animal) for regular?
Lispro? Aspart? Glargine |
human/pork
human human human |
|
which insulin is available for IV and IV injection pumps?
|
regular
|
|
which insulin formulation crystallizes into hexamer?
|
glargine
|
|
benefit of lispro
|
significantly improved glycemic control vs regular insulin, w/o hypoglycemia
|
|
which insulin prep is associated with low hypoglycemia
|
lispro
|
|
How does garlic affect clotting?
|
inhibits TX formation and platelet aggregation
|
|
how does ginkgo affect clotting?
|
inhbits PAF
|
|
how does feverfew affect clotting?
|
inhibits arachidonic acid synth
|
|
which type of arsenic is more toxic?
|
inorganic trivalent arsenic (2-10x more toxic than pentavalent)
|
|
how is inorganic arsenic toxic?
|
binds sulfhydryl groups on proteins
|
|
what toxicity is associated with arsine gas?
|
massive hemolysis
|
|
treatment for arsine gas toxicity?
|
chelation ineffective
use exchange transfusion and mannitol |
|
which chelator is exremely nephrotoxic?
treats? |
EDTA
lead poisoning |
|
which chelators can be given orally
|
DMPS
succimer penacillamine |